Product name: CJC-1295 WITH DAC 2mg
Bottle: Premium Glass Vial
Quantity: 1 x CJC-1295 WITH DAC 2mg
Classification: Premium Research Peptides
CJC-1295 with DAC is a performance peptide hormone that increases both the production of growth hormone and IGF-1 in healthy adult subjects.
In addition to this, CJC-1295 with DAC breaks down fat tissue, boosts injury recovery and enhanced bone density as well as reduces ageing factors such as skin wrinkles and improves skin quality.
CJC-1295 is sold in vials containing 2MG of lyophilised powder which can be reconstituted by adding a convenient amount of sterile or bacteriostatic water.
Elite Scientific Research:
CJC-1295 with DAC is a synthetic variant of growth hormone releasing hormone and is a performance peptide hormone that increases both the production of growth hormone and IGF-1 in healthy adult subjects.
A single injection in subjects increases plasma growth hormone levels by up to tenfold for six days and plasma IGF-1 levels by up to threefold for eleven days.
Because of its long half-life in humans it remains active for longer periods of time and increases the bioavailability of growth hormone releasing hormone.
In addition to this, CJC-1295 with DAC breaks down fat tissue, boosts injury recovery and enhances bone density.
It has also been purported to reduce ageing factors such as skin wrinkles and improve skin quality. This makes sense because peptide was initially being developed for the treatment of lipodystrophy and growth hormone deficiency and reached phase II clinical trials. It acts to help distribute fat deposits and adipose tissue which has a drastic impact on skin look and texture.
Teichman S. L., Neale A., Lawrence B., Gagnon C., Castaigne J., Frohman L. A., Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295, a Long-Acting Analog of GH-Releasing Hormone, in Healthy Adults, The Journal of Clinical Endocrinology & Metabolism, 2006, 91(3), 799–805.
Henninge J., Pepaj M., Hullstein I., Hemmersbach P., Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation, 2010, Drug Test Analysis, 2(1), 647–650.